Literature DB >> 3235512

An improved method for the simultaneous determination of morphine and its principal glucuronide metabolites.

S P Joel1, R J Osborne, M L Slevin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3235512     DOI： 10.1016/s0378-4347(00)83176-x

Source DB:  PubMed          Journal:  J Chromatogr


× No keyword cloud information.
  13 in total

1.  Blood-brain barrier transport and brain distribution of morphine-6-glucuronide in relation to the antinociceptive effect in rats--pharmacokinetic/pharmacodynamic modelling.

Authors:  M R Bouw; R Xie; K Tunblad; M Hammarlund-Udenaes
Journal:  Br J Pharmacol       Date:  2001-12       Impact factor: 8.739

2.  Pharmacokinetics and efficacy of rectal versus oral sustained-release morphine in cancer patients.

Authors:  T J Wilkinson; B A Robinson; E J Begg; S B Duffull; P J Ravenscroft; J J Schneider
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

3.  Plasma morphine-3-glucuronide, morphine-6-glucuronide and morphine concentrations in patients receiving long-term epidural morphine.

Authors:  J J Schneider; P J Ravenscroft; J D Cavenagh; A M Brown; J P Bradley
Journal:  Br J Clin Pharmacol       Date:  1992-11       Impact factor: 4.335

4.  Further development of a morphine hydrogel suppository.

Authors:  L Cole; C D Hanning; S Robertson; K Quinn
Journal:  Br J Clin Pharmacol       Date:  1990-12       Impact factor: 4.335

5.  Morphine and morphine-6-glucuronide in the plasma and cerebrospinal fluid of children.

Authors:  R D Hain; A Hardcastle; C R Pinkerton; G W Aherne
Journal:  Br J Clin Pharmacol       Date:  1999-07       Impact factor: 4.335

6.  The pharmacokinetics of morphine and morphine glucuronide metabolites after subcutaneous bolus injection and subcutaneous infusion of morphine.

Authors:  R Stuart-Harris; S P Joel; P McDonald; D Currow; M L Slevin
Journal:  Br J Clin Pharmacol       Date:  2000-03       Impact factor: 4.335

7.  Morphine blood-brain barrier transport is influenced by probenecid co-administration.

Authors:  Karin Tunblad; E Niclas Jonsson; Margareta Hammarlund-Udenaes
Journal:  Pharm Res       Date:  2003-04       Impact factor: 4.200

8.  Direct nose-to-brain transfer of morphine after nasal administration to rats.

Authors:  Ulrika Espefält Westin; Emma Boström; Johan Gråsjö; Margareta Hammarlund-Udenaes; Erik Björk
Journal:  Pharm Res       Date:  2006-02-25       Impact factor: 4.200

9.  Morphine 6-glucuronide: a metabolite of morphine with greater emetic potency than morphine in the ferret.

Authors:  P I Thompson; S Bingham; P L Andrews; N Patel; S P Joel; M L Slevin
Journal:  Br J Pharmacol       Date:  1992-05       Impact factor: 8.739

10.  The influence of age on the distribution of morphine and morphine-3-glucuronide across the blood-brain barrier in sheep.

Authors:  J Bengtsson; P Ederoth; D Ley; S Hansson; I Amer-Wåhlin; L Hellström-Westas; K Marsál; C-H Nordström; M Hammarlund-Udenaes
Journal:  Br J Pharmacol       Date:  2009-05-11       Impact factor: 8.739
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.